THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH
The trust's mission is to investigate, study and carry out, or procure the carrying out of, research into the causes and means of treatment of rheumatism and allied diseases.
Objects
The Objects for which the Charity is established are to provide financial and other support, infrastructure and training in scientific and clinical research that enhances understanding of rheumatic disorders and related immune mediated conditions, as well as the application of this research for the benefit of patients.
Financial health, per its FY2025 accounts
The accounts state that total unrestricted reserves stood at £331.7 million, with a general fund of £327.6 million, providing substantial liquidity. The charity carries out no fundraising activities and relies entirely on investment returns, which generated a net gain of £26 million in the year. The trustees confirm that resources are adequate to continue operations with no material uncertainties identified.
What the accounts disclose
“the Trust’s policy is to maintain the real value of the level of reserves over the long-term”
“one of the Trust’s 2024 Research Ignition Awards was granted to the University of Cambridge during the year. The project was led by Professor Paul Lehner, a non-Trustee member of the Research Committee. The total grant awarded was £99,970, with £58,148 outstanding at the start of the year. £58,100 was paid during the year, £48 was written back and there were no payments remaining at the year end.” — page 36
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints policy and procedures
- Conflicting interests
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 30/09/2025
- Employees paid over £60,000: 2 (£60,001–£70,000: 1; £120,001–£130,000: 1)
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 30/09/2024
- Employees paid over £60,000: 2 (£60,001–£70,000: 1; £110,001–£120,000: 1)
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 30/09/2023
- Employees paid over £60,000: 1 (£110,001–£120,000: 1)
- Grant-making is its main activity
Corporate structure
- Registered company of the charity Companies House 00963832
Company officers (Companies House)
- HESSEL, Edith Margarethe, Dr on trustee list
- WOOD, Anthony, Dr on trustee list
- TAK, Paul Peter, Professor on trustee list
- EMERY, Paul, Professor on trustee list
- CRONLY, Joseph Henry on trustee list
- PATEL, Harsha on trustee list
- PATTON, Michael Alexander, Professor on trustee list
- PUNT, Richard Kenneth on trustee list
- SATCHELL, Paul Wayne, Dr on trustee list
- COOMBE, Christopher John on trustee list
- DIGHERO, Mark Stefano on trustee list
- MIDDLETON, Hazel Fiona
Structured financials (annual return, FY ending 30/09/2025)
Trustees
- PROFESSOR STEPHEN TOWNLEY HOLGATEchair
- Christopher John Coombe
- Dr Anthony Wood
- Dr Edith Margarethe Hessel
- Dr Paul Wayne Satchell
- Harsha Patel
- JOSEPH CRONLY
- Mark Stefano Dighero
- Prof Tracy Hussell
- Professor Michael Alexander Patton
- Professor Paul Emery
- Professor Paul Peter Tak
- Richard Kenneth Punt
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £11.3m | £5.8m |
| 30/09/2024 | £10.7m | £7.0m |
| 30/09/2023 | £8.9m | £17.4m |
| 30/09/2022 | £8.7m | £7.7m |
| 30/09/2021 | £10.8m | £20.8m |
Common questions
Is THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH financially healthy?
Per its FY2025 accounts: The accounts state that total unrestricted reserves stood at £331.7 million, with a general fund of £327.6 million, providing substantial liquidity. The charity carries out no fundraising activities and relies entirely on investment returns, which generated a net gain of £26 million in the year. The trustees confirm that resources are adequate to continue operations with no material uncertainties identified. Its FY2025 accounts were audited by MHA.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE STONEYGATE TRUST | 1 | £2.6m |
| THE THOMPSON FAMILY CHARITABLE TRUST | 1 | £345k |
| THE CAPRICORN FOUNDATION | 1 | £275k |
| THE CATHERINE COOKSON CHARITABLE TRUST | 1 | £75k |
| THE KIDNEY FUND | 1 | £40k |
| THE JOSEPH AND LILIAN SULLY FOUNDATION | 1 | £25k |
| THE LESLIE SMITH FOUNDATION | 1 | £20k |
| THE ORR MACKINTOSH FOUNDATION LIMITED | 1 | £20k |
Charities like this
- TRAFFORD RENAL RESEARCH TRUST
- THE CHARTERHOUSE RHEUMATISM CHARITY
- KD-UK, KENNEDY'S DISEASE UK
- KIDNEY RESEARCH UK
- THE THROMBOSIS RESEARCH TRUST
- HAYWOOD RHEUMATISM RESEARCH AND DEVELOPMENT FOUNDATION
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH | £11.3m | — | — | above | — | no doubt |
| TRAFFORD RENAL RESEARCH TRUST | £95k | — | 0 | unclear | — | no doubt |
| THE CHARTERHOUSE RHEUMATISM CHARITY | £125k | — | 0 | unclear | — | no doubt |
| KD-UK, KENNEDY'S DISEASE UK | £40k | — | 0 | unclear | — | no doubt |
| KIDNEY RESEARCH UK | £14.5m | £130,001 - £140,000 | — | within | — | no doubt |
| THE THROMBOSIS RESEARCH TRUST | £181k | — | 0 | above | — | no doubt |